Working… Menu

A Phase 1 Study of an Investigational Drug, ALN-PCSSC, in Subjects With Elevated Low Density Lipoprotein Cholesterol (LDL-C)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02314442
Recruitment Status : Completed
First Posted : December 11, 2014
Last Update Posted : December 17, 2015
The Medicines Company
Information provided by (Responsible Party):
Alnylam Pharmaceuticals

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : May 2015
Actual Study Completion Date : November 2015